REPOXYGEN
DEAD

Serial Number

78430797

Owner

Oxford BioMedica plc

Attorney

Purvi J. Patel

Filing Date

Jun 7, 2004

Add to watchlist:

No watchlists yet
View on USPTO

REPOXYGEN Trademark

Serial Number: 78430797 • Registration: 3182505

REPOXYGEN is a trademark filed by Oxford BioMedica plc on June 7, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oxford BioMedica plc (54 trademarks)

Medawar Centre, Robert Robinson Avenue
Oxford, OX4 4GA , GB

Entity Type: 03

Trademark Details

Filing Date

June 7, 2004

Registration Date

December 12, 2006

Published for Opposition

September 26, 2006

Cancellation Date

July 19, 2013

Goods & Services

Gene therapy and prophylaxis products, pharmaceutical substances and preparations, and chemical products for use in medical science, all for haematological disorders; vaccines, enzymes and enzyme preparations, pharmaceuticals for the delivery of erythropoietin genes to muscle cells, all for medical purposes; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of anaemia

Chemical products for use in industry and science; enzymes; chemical products for in-vitro use in laboratories and for analysis; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles, namely chemical products for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use

Instruments and apparatus for the administration of gene therapy and prophylaxis preparations and substances, pre-filled vials; syringes and injectors for medical purposes

Scientific and medical research and development; genetic engineering services, biotechnology services, licensing of intellectual property, advisory services relating to gene therapy products

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 19, 2013 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2008 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2008 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 12, 2006 R.PR
PUBLISHED FOR OPPOSITION
Sep 26, 2006 PUBO
NOTICE OF PUBLICATION
Sep 6, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 31, 2006 PREV
ASSIGNED TO LIE
Jul 28, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2006 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 23, 2006 TROA
NON-FINAL ACTION MAILED
Feb 2, 2006 CNRT
NON-FINAL ACTION WRITTEN
Feb 1, 2006 CNRT
AMENDMENT FROM APPLICANT ENTERED
Sep 23, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2005 CRFA
FAX RECEIVED
Aug 17, 2005 FAXX
INQUIRY AS TO SUSPENSION MAILED
Jul 14, 2005 CNSI
SUSPENSION INQUIRY WRITTEN
Jul 13, 2005 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 11, 2005 RCCK
LETTER OF SUSPENSION MAILED
Jan 10, 2005 CNSL
SUSPENSION LETTER WRITTEN
Jan 8, 2005 CNSL
ASSIGNED TO EXAMINER
Jan 7, 2005 DOCK
NEW APPLICATION ENTERED
Jun 14, 2004 NWAP